Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-4,645
Closed -$375K 69
2023
Q1
$375K Sell
4,645
-4,340
-48% -$349K 0.41% 47
2022
Q4
$672K Sell
8,985
-3
-0% -$214 0.77% 42
2022
Q3
$580K Sell
8,988
-1,268
-12% -$87.8K 0.71% 43
2022
Q2
$711K Buy
10,256
+160
+2% +$11.9K 0.78% 42
2022
Q1
$776K Buy
10,096
+273
+3% +$19.6K 0.77% 41
2021
Q4
$752K Buy
+9,823
New +$722K 0.7% 44

Other funds holding HOLX

DB Fitzpatrick & Co's HOLX Position: Q2 2023 in Review

DB Fitzpatrick & Co sold out of Hologic (HOLX) in Q2 2023, closing a stake of 4,645 shares — an estimated $375K sold.

DB Fitzpatrick & Co first reported a position in HOLX in Q4 2021 and held it in 6 quarters. The position peaked at $776K in Q1 2022. 713 funds tracked by Wall St. Rank hold HOLX as of Q2 2023.

  • DB Fitzpatrick & Co reported no remaining Hologic position as of Q2 2023 after selling out during the quarter.
  • DB Fitzpatrick & Co sold 4,645 Hologic shares in Q2 2023, an estimated $375K.
  • DB Fitzpatrick & Co first reported a position in Hologic in Q4 2021 and held it in 6 quarters.
  • DB Fitzpatrick & Co's Hologic position peaked at $776K in Q1 2022.
  • 713 funds tracked by Wall St. Rank held Hologic as of Q2 2023.

Based on DB Fitzpatrick & Co's 13F filing for Q2 2023, filed 9 Aug 2023.